Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia

Abstract

Cytogenetics plays an important role in the molecular characterization of ALL defining the prognostic subgroups. Patients with unfavorable cytogenetics and with t(9;22) have poorer outcomes.